Orexo Us Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OREXO US INC, and when can generic versions of OREXO US INC drugs launch?
OREXO US INC has one approved drug.
There are ten US patents protecting OREXO US INC drugs.
There are forty-seven patent family members on OREXO US INC drugs in thirty-one countries.
Drugs and US Patents for Orexo Us Inc
Expired US Patents for Orexo Us Inc
Paragraph IV (Patent) Challenges for OREXO US INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Sublingual Tablets | 1.4 mg/0.36 mg and 5.7 mg/1.4 mg | ➤ Subscribe | 2013-10-22 |
➤ Subscribe | Sublingual Tablets | 2.9 mg/7.1 mg | ➤ Subscribe | 2015-12-21 |
➤ Subscribe | Sublingual Tablets | 8.6 mg/2.1 mg and 11.4 mg/2.9 mg | ➤ Subscribe | 2015-07-24 |
➤ Subscribe | Sublingual tablets | 0.7 mg/0.18 mg | ➤ Subscribe | 2017-05-03 |
International Patents for Orexo Us Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2834327 | ⤷ Try a Trial |
Montenegro | 02153 | ⤷ Try a Trial |
Poland | 2101740 | ⤷ Try a Trial |
Denmark | 2101740 | ⤷ Try a Trial |
Mexico | 361757 | ⤷ Try a Trial |
Poland | 2915525 | ⤷ Try a Trial |
Spain | 2538460 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.